TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
04 2021
Historique:
revised: 29 12 2020
received: 04 12 2019
accepted: 05 02 2021
pubmed: 11 2 2021
medline: 1 4 2022
entrez: 10 2 2021
Statut: ppublish

Résumé

Thousand and one amino-acid kinase 1 (TAOK1) is a MAP3K protein kinase, regulating different mitogen-activated protein kinase pathways, thereby modulating a multitude of processes in the cell. Given the recent finding of TAOK1 involvement in neurodevelopmental disorders (NDDs), we investigated the role of TAOK1 in neuronal function and collected a cohort of 23 individuals with mostly de novo variants in TAOK1 to further define the associated NDD. Here, we provide evidence for an important role for TAOK1 in neuronal function, showing that altered TAOK1 expression levels in the embryonic mouse brain affect neural migration in vivo, as well as neuronal maturation in vitro. The molecular spectrum of the identified TAOK1 variants comprises largely truncating and nonsense variants, but also missense variants, for which we provide evidence that they can have a loss of function or dominant-negative effect on TAOK1, expanding the potential underlying causative mechanisms resulting in NDD. Taken together, our data indicate that TAOK1 activity needs to be properly controlled for normal neuronal function and that TAOK1 dysregulation leads to a neurodevelopmental disorder mainly comprising similar facial features, developmental delay/intellectual disability and/or variable learning or behavioral problems, muscular hypotonia, infant feeding difficulties, and growth problems.

Identifiants

pubmed: 33565190
doi: 10.1002/humu.24176
pmc: PMC8248425
doi:

Substances chimiques

Amino Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-459

Subventions

Organisme : Medical Research Council
ID : MC_UU_00007/3
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Human Mutation published by Wiley Periodicals LLC.

Références

Nat Med. 2019 Jan;25(1):60-64
pubmed: 30617323
Mol Psychiatry. 2019 Sep;24(9):1329-1350
pubmed: 29467497
Genet Med. 2018 Oct;20(10):1216-1223
pubmed: 29323667
Mol Cytogenet. 2016 May 31;9:41
pubmed: 27247625
Commun Integr Biol. 2011 Sep;4(5):554-6
pubmed: 22046460
Am J Hum Genet. 2015 Sep 3;97(3):378-88
pubmed: 26340333
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
EMBO J. 2007 Apr 18;26(8):2005-14
pubmed: 17396146
Genet Med. 2017 Feb;19(2):224-235
pubmed: 27513193
Mol Biol Cell. 2002 Nov;13(11):4013-28
pubmed: 12429843
Hum Mutat. 2021 Apr;42(4):445-459
pubmed: 33565190
Cell Mol Immunol. 2018 Aug;15(8):794-802
pubmed: 29400705
Neuroscience. 2001;103(4):865-72
pubmed: 11301197
J Biol Chem. 2006 Mar 17;281(11):7317-23
pubmed: 16407310
Am J Hum Genet. 2017 Nov 2;101(5):768-788
pubmed: 29100089
Hum Genet. 2017 Apr;136(4):349-376
pubmed: 28213670
Dev Biol. 2001 Dec 1;240(1):237-46
pubmed: 11784059
Genet Med. 2015 Jul;17(7):578-86
pubmed: 25356970
J Neurosci. 2011 Jan 19;31(3):1139-48
pubmed: 21248138
Hum Mutat. 2018 Dec;39(12):2008-2024
pubmed: 30184290
J Biol Chem. 1998 Oct 30;273(44):28625-32
pubmed: 9786855
J Neurosci. 2007 Jan 17;27(3):574-81
pubmed: 17234589
Trends Cell Biol. 2001 May;11(5):220-30
pubmed: 11316611
J Neurosci. 2015 Feb 18;35(7):3190-200
pubmed: 25698753
Curr Biol. 2016 Apr 25;26(8):1034-42
pubmed: 26996505
Genet Med. 2016 Jul;18(7):696-704
pubmed: 26633542
Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81
pubmed: 25883148
N Engl J Med. 2008 Feb 14;358(7):667-75
pubmed: 18184952
Neuroscientist. 2012 Apr;18(2):169-79
pubmed: 21551077
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Nat Cell Biol. 2007 May;9(5):556-64
pubmed: 17417629
EMBO J. 2003 Oct 1;22(19):5090-101
pubmed: 14517247
Am J Hum Genet. 2016 Oct 6;99(4):934-941
pubmed: 27616479
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843
Nat Commun. 2017 Oct 20;8(1):1052
pubmed: 29051493
J Neurosci. 1988 Apr;8(4):1454-68
pubmed: 3282038
Am J Hum Genet. 2019 Jul 3;105(1):213-220
pubmed: 31230721

Auteurs

Geeske M van Woerden (GM)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.
Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Melanie Bos (M)

Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Charlotte de Konink (C)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Ben Distel (B)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.
Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Rossella Avagliano Trezza (R)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Natasha E Shur (NE)

Division of Genetics and Metabolism, Rare Disease Institute, Children's National Medical Center, Washington, District of Columbia, USA.

Kristin Barañano (K)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.

Sonal Mahida (S)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.

Anna Chassevent (A)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.

Allison Schreiber (A)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Angelika L Erwin (AL)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Karen W Gripp (KW)

Division of Medical Genetics, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, USA.

Fatima Rehman (F)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Saskia Brulleman (S)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Róisín McCormack (R)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Gwynna de Geus (G)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.

Louisa Kalsner (L)

Departments of Neurology and Pediatrics, Connecticut Children's Medical Center and University of Connecticut School of Medicine, Farmington, Connecticut, USA.

Arthur Sorlin (A)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.
Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Centre de Référence maladies rares «Anomalies du Développement et syndromes malformatifs», Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Ange-Line Bruel (AL)

UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.
Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Centre de Référence maladies rares «Anomalies du Développement et syndromes malformatifs», Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

David A Koolen (DA)

Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Melissa K Gabriel (MK)

Department of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.

Mari Rossi (M)

Department of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.

David R Fitzpatrick (DR)

MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, UK.

Andrew O M Wilkie (AOM)

Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Oxford Craniofacial Unit, Oxford University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Eduardo Calpena (E)

Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

David Johnson (D)

Oxford Craniofacial Unit, Oxford University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Alice Brooks (A)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Marjon van Slegtenhorst (M)

Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Julie Fleischer (J)

Department of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.

Daniel Groepper (D)

Department of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.

Kristin Lindstrom (K)

Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, Arizona, USA.

A Micheil Innes (AM)

Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Allison Goodwin (A)

VCU Medical Center, Clinical Genetics Services, Richmond, Virginia, USA.

Jennifer Humberson (J)

Division of Pediatric Genetics, Department of Pediatrics, University of Virginia Medical Center, Charlottesville, Virginia, USA.

Amanda Noyes (A)

GeneDx, Gaithersburg, Maryland, USA.

Katherine G Langley (KG)

GeneDx, Gaithersburg, Maryland, USA.

Aida Telegrafi (A)

GeneDx, Gaithersburg, Maryland, USA.

Amy Blevins (A)

GeneDx, Gaithersburg, Maryland, USA.

Jessica Hoffman (J)

GeneDx, Gaithersburg, Maryland, USA.

Maria J Guillen Sacoto (MJ)

GeneDx, Gaithersburg, Maryland, USA.

Jane Juusola (J)

GeneDx, Gaithersburg, Maryland, USA.

Kristin G Monaghan (KG)

GeneDx, Gaithersburg, Maryland, USA.

Sumit Punj (S)

GeneDx, Gaithersburg, Maryland, USA.

Marleen Simon (M)

Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Rolph Pfundt (R)

Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Ype Elgersma (Y)

Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.

Tjitske Kleefstra (T)

Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH